SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 387.32 |
| Enterprise Value ($M) | 313.30 |
| Book Value ($M) | 126.48 |
| Book Value / Share | 3.34 |
| Price / Book | 3.06 |
| NCAV ($M) | 91.28 |
| NCAV / Share | 2.41 |
| Price / NCAV | 4.24 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.63 |
| Return on Assets (ROA) | -0.42 |
| Return on Equity (ROE) | -0.52 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 8.94 |
| Current Ratio | 8.94 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 129.73 |
| Assets | 164.94 |
| Liabilities | 38.46 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -104.31 |
| Net Income | -96.02 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -94.18 |
| Cash from Investing | 9.69 |
| Cash from Financing | 3.12 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Adage Capital Partners Gp, L.l.c. | 7.25 | ||
| 13G | Artal International S.C.A. | 7.30 | ||
| 13D/A | Perceptive Advisors Llc | 18.60 | 97.79 | |
| 13D/A | BCLS SB Investco, LP | 6.20 | 0.00 | |
| 13G | Flynn James E | 6.08 | ||
| 13D/A | Ra Capital Management, L.p. | 11.70 | 26.73 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| ` UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| m` UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| ` UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 29,714 | 667,345 | 4.45 | |
| 70,769 | 75,642 | 93.56 | |
| 16,334 | 32,521 | 50.23 | |
| 34,765 | 46,638 | 74.54 | |
| 16,822 | 37,192 | 45.23 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SCPH – scPharmaceuticals Inc. | SDGR – Schrödinger, Inc. |
| SGMO – Sangamo Therapeutics, Inc. | SLRN – Acelyrin, Inc. |
| SNDX – Syndax Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io